Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium.

COVID-19 bronchoalveolar lavage infections interstitial pneumonia interventional pulmonology

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2024
Historique:
received: 16 07 2023
accepted: 09 01 2024
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 19 2 2024
Statut: epublish

Résumé

Diagnosing COVID-19 and treating its complications remains a challenge. This review reflects the perspective of some of the Dragon (IMI 2-call 21, #101005122) research consortium collaborators on the utility of bronchoalveolar lavage (BAL) in COVID-19. BAL has been proposed as a potentially useful diagnostic tool to increase COVID-19 diagnosis sensitivity. In both critically ill and non-critically ill COVID-19 patients, BAL has a relevant role in detecting other infections or supporting alternative diagnoses and can change management decisions in up to two-thirds of patients. BAL is used to guide steroid and immunosuppressive treatment and to narrow or discontinue antibiotic treatment, reducing the use of unnecessary broad antibiotics. Moreover, cellular analysis and novel multi-omics techniques on BAL are of critical importance for understanding the microenvironment and interaction between epithelial cells and immunity, revealing novel potential prognostic and therapeutic targets. The BAL technique has been described as safe for both patients and healthcare workers in more than a thousand procedures reported to date in the literature. Based on these preliminary studies, we recognize that BAL is a feasible procedure in COVID-19 known or suspected cases, useful to properly guide patient management, and has great potential for research.

Identifiants

pubmed: 38371516
doi: 10.3389/fmed.2024.1259570
pmc: PMC10869531
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1259570

Informations de copyright

Copyright © 2024 Tomassetti, Ciani, Luzzi, Gori, Trigiani, Giuntoli, Lavorini, Poletti, Ravaglia, Torrego, Maldonado, Lentz, Annunziato, Maggi, Rossolini, Pollini, Para, Ciurleo, Casini, Rasero, Bartoloni, Spinicci, Munavvar, Gasparini, Comin, Cerinic, Peired, Henket, Ernst, Louis, Corhay, Nardi and Guiot.

Déclaration de conflit d'intérêts

ST declares consultancy and speaker’s fees from Roche and Boehringer Ingelheim. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Sara Tomassetti (S)

Interventional Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Luca Ciani (L)

Interventional Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Valentina Luzzi (V)

Interventional Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Leonardo Gori (L)

Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Marco Trigiani (M)

Interventional Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Leonardo Giuntoli (L)

Interventional Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Federico Lavorini (F)

Pulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.

Venerino Poletti (V)

Department of Diseases of the Thorax, GB Morgagni Hospital, Forlì, Italy.

Claudia Ravaglia (C)

Department of Diseases of the Thorax, GB Morgagni Hospital, Forlì, Italy.

Alfons Torrego (A)

Respiratory Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Fabien Maldonado (F)

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, United States.

Robert Lentz (R)

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, United States.

Francesco Annunziato (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Laura Maggi (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Gian Maria Rossolini (GM)

Department of Experimental Medicine, University of Florence, Florence, Italy.
Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.

Simona Pollini (S)

Department of Experimental Medicine, University of Florence, Florence, Italy.
Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.

Ombretta Para (O)

Internal Medicine Unit 1, AOU Careggi, Florence, Italy.

Greta Ciurleo (G)

Internal Medicine Unit 2, AOU Careggi, Florence, Italy.

Alessandro Casini (A)

Internal Medicine Unit 2, AOU Careggi, Florence, Italy.

Laura Rasero (L)

Department of Health Science, Clinical Innovations and Research Unit, Careggi University Hospital, Florence, Italy.

Alessandro Bartoloni (A)

Infectious and Tropical Diseases Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Michele Spinicci (M)

Infectious and Tropical Diseases Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Mohammed Munavvar (M)

School of Biological Sciences, The University of Manchester, Manchester, United Kingdom.
Department of Respiratory, Lancashire Teaching Hospital NHS Foundation Trust, Preston, United Kingdom.

Stefano Gasparini (S)

Interventional Pulmonology Unit, University Hospital Riuniti di Ancona, Ancona, Italy.

Camilla Comin (C)

Department of Experimental and Clinical Medicine Section of Surgery, Histopathology, and Molecular Pathology, University of Florence, Florence, Italy.

Marco Matucci Cerinic (MM)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Anna Peired (A)

Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy.

Monique Henket (M)

Department of Respiratory Medicine, Universitary Hospital of Liège, Liège, Belgium.

Benoit Ernst (B)

Department of Respiratory Medicine, Universitary Hospital of Liège, Liège, Belgium.

Renaud Louis (R)

Department of Respiratory Medicine, Universitary Hospital of Liège, Liège, Belgium.

Jean-Louis Corhay (JL)

Department of Respiratory Medicine, Universitary Hospital of Liège, Liège, Belgium.

Cosimo Nardi (C)

Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence, Florence, Italy.

Julien Guiot (J)

Department of Respiratory Medicine, Universitary Hospital of Liège, Liège, Belgium.

Classifications MeSH